- Non-Valved Glaucoma Drainage implants
- Valved Glaucoma Drainage implants
Glaucoma Implants Market size was valued at USD 582.6 million in 2022 and is poised to grow at a CAGR of 27.2% from 2023-2029. Notwithstanding customary and laser medical procedures, there are an assortment of medications to bring down intraocular weight (IOP). On the off chance that these strategies alone come up short, specialists may propose inserts. Otherwise called aqueous shunts or glaucoma drainage devices, we allude to them essentially as implants. The expanding number of instances of glaucoma is the crucial component that is probably going to empower the development of the worldwide glaucoma implant market in the following couple of years. The simple accessibility of restorative protection scope for treatment and analysis is evaluated to make lucrative open doors for the conspicuous players working in the worldwide glaucoma implants market in the coming years. Moreover, the expanding geriatric populace and the rising medicinal services consumption are anticipated to fuel the development of the glaucoma implants market. On the other hand, stringent government controls concerning marketing and approvals are anticipated to limit the development of the market.
Glaucoma Implants Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
27.2%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Glaucoma Implants Market Dynamics
Worldwide glaucoma implants market is exceedingly divided with a few nearby and global players offering diverse implantable items in the commercial center. Players or specialist organizations in the glaucoma implants market are concocting altered arrangement that tends to the patient prerequisites. Players in glaucoma implants market are creating fresher outlines which are impacted by viscoelastic innovation and others to increase bigger market income share in the visual inserts showcase. Glaucoma is one of the main sources of visual impairment all around. As indicated by information distributed by the Glaucoma Research Foundation, in 2016, around 3.0 million individuals in America were experiencing Glaucoma. With expanding frequency of glaucoma, the interest for glaucoma implants is relied upon to increment, accordingly, powering the market development.
North-America Got Significant Share of
Glaucoma Implants Market Regional Analysis
Geographically Glaucoma Implants Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America is a standout amongst the most lucrative region for glaucoma implants because of developing maturing populace and simple accessibility of repayment offices, which help the territorial market. The U.S. is most commanding nation in this locale, attributable to a substantial populace having strong protection scope, innovative headways, and maturing populace. Europe is relied upon to witness vigorous development inferable from expanded number of eye medical procedures, nearness of key players in the region. Also, enter players in the glaucoma implants are significantly concentrating on both created and creating districts markets to tap the expanded market interest for glaucoma implants. The Asia Pacific is foreseen to enlist positive development attributable to ideal patient socioeconomics and creating medicinal services foundation in the glaucoma implants area.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The glaucoma implants market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Glaucoma Implants Market Segmentation
By Type
By Disease Condition
- Closed Angle Glaucoma (CAG)
- Open Angle Glaucoma (OAG)
- Secondary Glaucoma
- Congenital Glaucoma
- Other
By End User
- Eye Hospitals
- Ophthalmology Clinics
- Outpatient Surgical Centers
Frequently Asked Questions
The glaucoma implants market size was valued at USD 572.6 million in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The glaucoma implants market key players are Novartis AG (Switzerland), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Allergan, Inc. (U.S.), Opcon Corporation (Japan)
| 1.Executive Summary |
| 2.Global Gastric Cancer Treatment Market Introduction |
| 2.1.Global Gastric Cancer Treatment Market - Taxonomy |
| 2.2.Global Gastric Cancer Treatment Market - Definitions |
| 2.2.1. By Type |
| 2.2.2. By Disease Condition |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3.Global Gastric Cancer Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Gastric Cancer Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Gastric Cancer Treatment Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Non-Valved Glaucoma Drainage implants |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Valved Glaucoma Drainage implants |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Gastric Cancer Treatment Market By Disease Condition, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Closed Angle Glaucoma (CAG) |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Open Angle Glaucoma (OAG) |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Secondary Glaucoma |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Congenital Glaucoma |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Gastric Cancer Treatment Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Eye Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ophthalmology Clinics |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Outpatient Surgical Centers |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Gastric Cancer Treatment Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Gastric Cancer Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Non-Valved Glaucoma Drainage implants |
| 9.1.2.Valved Glaucoma Drainage implants |
| 9.2. Disease Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Closed Angle Glaucoma (CAG) |
| 9.2.2.Open Angle Glaucoma (OAG) |
| 9.2.3.Secondary Glaucoma |
| 9.2.4.Congenital Glaucoma |
| 9.2.5.Other |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Eye Hospitals |
| 9.3.2.Ophthalmology Clinics |
| 9.3.3.Outpatient Surgical Centers |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Gastric Cancer Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Non-Valved Glaucoma Drainage implants |
| 10.1.2.Valved Glaucoma Drainage implants |
| 10.2. Disease Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Closed Angle Glaucoma (CAG) |
| 10.2.2.Open Angle Glaucoma (OAG) |
| 10.2.3.Secondary Glaucoma |
| 10.2.4.Congenital Glaucoma |
| 10.2.5.Other |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Eye Hospitals |
| 10.3.2.Ophthalmology Clinics |
| 10.3.3.Outpatient Surgical Centers |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Gastric Cancer Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Non-Valved Glaucoma Drainage implants |
| 11.1.2.Valved Glaucoma Drainage implants |
| 11.2. Disease Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Closed Angle Glaucoma (CAG) |
| 11.2.2.Open Angle Glaucoma (OAG) |
| 11.2.3.Secondary Glaucoma |
| 11.2.4.Congenital Glaucoma |
| 11.2.5.Other |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Eye Hospitals |
| 11.3.2.Ophthalmology Clinics |
| 11.3.3.Outpatient Surgical Centers |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Gastric Cancer Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Non-Valved Glaucoma Drainage implants |
| 12.1.2.Valved Glaucoma Drainage implants |
| 12.2. Disease Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Closed Angle Glaucoma (CAG) |
| 12.2.2.Open Angle Glaucoma (OAG) |
| 12.2.3.Secondary Glaucoma |
| 12.2.4.Congenital Glaucoma |
| 12.2.5.Other |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Eye Hospitals |
| 12.3.2.Ophthalmology Clinics |
| 12.3.3.Outpatient Surgical Centers |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Gastric Cancer Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Non-Valved Glaucoma Drainage implants |
| 13.1.2.Valved Glaucoma Drainage implants |
| 13.2. Disease Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Closed Angle Glaucoma (CAG) |
| 13.2.2.Open Angle Glaucoma (OAG) |
| 13.2.3.Secondary Glaucoma |
| 13.2.4.Congenital Glaucoma |
| 13.2.5.Other |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Eye Hospitals |
| 13.3.2.Ophthalmology Clinics |
| 13.3.3.Outpatient Surgical Centers |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Novartis AG (Switzerland) |
| 14.2.2.Carl Zeiss Meditech AG (Germany) |
| 14.2.3. Abbott Laboratories (U.S.) |
| 14.2.4.Essilor International S.A. (France) |
| 14.2.5.Allergan, Inc. (U.S.) |
| 14.2.6.Opcon Corporation (Japan) |
| 14.2.7.NIDEK Co., Ltd. (Japan) |
| 14.2.8.Bausch & Lomb, Inc. (U.S.) |
| 14.2.9.STAAR Surgical Company (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Novartis AG (Switzerland)
- Carl Zeiss Meditech AG (Germany)
- Abbott Laboratories (U.S.)
- Essilor International S.A. (France)
- Allergan, Inc. (U.S.)
- Opcon Corporation (Japan)
- NIDEK Co., Ltd. (Japan)
- Bausch & Lomb, Inc. (U.S.)
- STAAR Surgical Company (U.S.)